Britain to map 100 000 DNA code sequences

2014-08-01 12:03


Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

London - British scientists are to map 100 000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister said on Friday.

David Cameron announced £300 million in deals to fund the mapping project, predicted to be complete by 2017.

The project will sequence the genetic codes of about 75 000 patients with cancer and rare diseases, and those of their close relatives.

Both the healthy and the tumour cells of the cancer patients will be mapped, meaning about 100 000 will be sequenced in total.

"This agreement will see the UK lead the world in genetic research within years," Cameron said.

"As our plan becomes a reality, I believe we will be able to transform how devastating diseases are diagnosed and treated in the NHS and across the world."

Personalised treatments

Scientists hope that identifying tiny changes in the genetic code that can trigger disease will allow for personalised and more effective treatments.

An example of this kind of therapy is Herceptin, a drug which treats a breast cancer variant characterised by over-activity of the Her2 gene.

DNA samples have already been donated by a few hundred participants in a pilot, and about 10 000 are expected to have donated by the end of the year.

Among the cancers due to be targeted are bowel, breast, leukaemia, lung, ovarian, prostate and leukaemia.

Charity the Wellcome Trust, the Medical Research Council and Britain's National Health Service are contributing to the project, which will be overseen by Genomics England, set up by the Department of Health.

The Californian DNA sequencing company Illumina, which won a contract to provide the technology for the project, will also invest about 162 million in the project over its lifetime.

Wellcome Trust director Jeremy Farrar said genome sequencing could transform medicine.

"Twenty years from now academics and industry will have developed therapies which will be targeted at you and specific forms of cancer," Farrar said.

"We will look back in 20 years time and the blockbuster chemotherapy drugs that gave you all those nasty side effects will be a thing of the past."

Read more on:    britain  |  health

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.